Navigation Links
Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
Date:2/27/2009

NEW CASTLE, Del., Feb. 27 /PRNewswire/ -- Arkion(R) Life Sciences has received a Section 18 Crisis Exemption to market Avipel(R) Corn Seed Treatment in Louisiana effective March 1, 2009. The EPA approval means that Louisiana farmers can use Avipel(R) to protect field and sweet corn from marauding blackbirds and grackles for the 2009 planting season. Formerly known as Avitec, Avipel(R) is applied to corn seed before planting and effectively stops birds from damaging crops by eating the newly planted seeds.

This is the first year Avipel(R) has received approval in Louisiana. The product is non-lethal to birds and has been shown to be highly effective in protecting corn seed from birds in over four years of use in states with particular bird problems such as Mississippi, Michigan, Minnesota, South Dakota and Wisconsin. Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site: www.ArkionLS.com.

According to Ken Ballinger (VP, Airepel(R)), Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. Arkion's patented formulations of anthraquinone have been effectively repelling geese with FlightControl(R) Plus and repelling birds from structures through the Airepel(R) Humane Bird Management business.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. The company has over 500 patents and patent applications worldwide around these technologies, including the area of feed preservation with N-Sure(R), and employs biotechnology to capitalize on new opportunities in the nutraceutical, pharmaceutical, animal health and agricultural markets. Arkion(R) has three major businesses: Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.


'/>"/>
SOURCE Arkion Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Crisis Management PR Firms Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny
2. Countering an approaching water crisis
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Life Science Labs Reacting to the Economic Crisis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
7. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
8. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
9. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
10. Odyssey Thera Granted U.S. Patent for Animal Imaging
11. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model ... world’s leading maker of unmanned aircraft systems (UAS), are launching a joint program ... drones effectively, and support educational outreach efforts. , AMA and DJI will collaborate ...
(Date:2/16/2017)... Brussels, Belgium (PRWEB) , ... February 16, 2017 , ... ... Development (SIOTAD) framework primarily aimed at the agricultural industry. Pilot studies are about to ... phytosanitary products through IoT, Big Data and 5G innovations. The concept is expected to ...
(Date:2/16/2017)... (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power of ... negative breast cancer (TNBC), announced today their completion of the ... The YEi Start in France ... business in France and Europe.  ImMAGE ... an intensive one week immersion in France ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):